当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 资产负债表

尔康制药

(300267)

  

流通市值:35.84亿  总市值:51.98亿
流通股本:14.22亿   总股本:20.63亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金959,996,364.24884,313,345.86976,834,945.24897,404,913.83
  交易性金融资产-20,000,00090,000,00090,000,000
  衍生金融资产23,636,8002,562,100--
  应收票据及应收账款151,236,215.07187,260,615.63163,181,967.78155,784,775.56
  其中:应收票据29,149,569.230,935,880.5833,964,991.334,792,695.91
        应收账款122,086,645.87156,324,735.05129,216,976.48120,992,079.65
  应收款项融资23,159,782.6229,288,355.9438,942,196.8646,609,251.17
  预付款项27,792,523.6921,163,051.4643,456,373.734,342,448.49
  其他应收款合计2,680,132.572,386,979.663,529,862.483,622,884.22
  存货694,619,530.29750,164,570.12523,930,100.38511,995,309.66
  其他流动资产79,349,447.1876,385,479.4379,273,211.6178,805,318.31
  流动资产合计1,962,470,795.661,973,524,498.11,919,148,658.081,788,564,901.24
非流动资产:
  长期股权投资49,680,018.4849,591,253.6849,753,379.5249,796,115.43
  其他权益工具投资50,000,00050,000,00050,000,00050,000,000
  投资性房地产72,472,985.0273,274,354.8774,075,724.6774,877,094.52
  固定资产1,963,304,993.591,995,501,401.732,024,647,726.092,052,034,605.35
  在建工程252,966,160.67192,680,667.39203,474,658.59212,280,768.93
  使用权资产150,289,472.05151,332,348.82156,221,733.02161,011,810.33
  无形资产303,316,640.36307,836,529.72312,643,182.3317,123,214.89
  商誉2,003,166.562,003,166.562,003,166.562,003,166.56
  长期待摊费用8,577,031.288,097,455.238,889,167.49,562,210.31
  递延所得税资产108,644,242.64112,988,761.87119,801,334.85120,402,235.4
  其他非流动资产118,399,445.2162,997,546.138,830,879.7223,368,123.24
  非流动资产合计3,079,654,155.863,006,303,485.973,040,340,952.723,072,459,344.96
  资产总计5,042,124,951.524,979,827,984.074,959,489,610.84,861,024,246.2
流动负债:
  短期借款669,173,693.3689,333,333.32684,508,487.65551,383,098.76
  应付票据及应付账款122,271,329.1142,946,446.34113,472,017.86121,072,034.17
        应付账款122,271,329.1142,946,446.34113,472,017.86121,072,034.17
  合同负债77,358,532.130,826,672.6139,538,415.3726,174,437.99
  应付职工薪酬12,489,725.6514,913,319.9412,414,386.7725,007,592.2
  应交税费3,942,082.35,179,050.243,136,590.678,745,803.43
  其他应付款合计39,948,177.3140,334,781.9140,467,336.5444,163,226.06
  一年内到期的非流动负债7,921,954.227,885,682.234,823,476.18,787,182.79
  其他流动负债20,485,715.2918,580,602.6118,545,378.4417,393,561.31
  流动负债合计953,591,209.27949,999,889.2916,906,089.4802,726,936.71
非流动负债:
  租赁负债25,302,364.8123,628,454.7327,715,257.227,858,917.41
  递延收益7,791,444.158,336,749.569,197,888.2910,059,027.01
  递延所得税负债44,903,798.3844,720,626.3346,354,118.3846,324,267.52
  非流动负债合计77,997,607.3476,685,830.6283,267,263.8784,242,211.94
  负债合计1,031,588,816.611,026,685,719.821,000,173,353.27886,969,148.65
所有者权益(或股东权益):
  实收资本(或股本)2,062,604,8702,062,604,8702,062,604,8702,062,604,870
  资本公积1,019,459,930.441,019,459,930.441,019,459,930.441,019,459,930.44
  其他综合收益4,364,562.01-29,594,433.361,494,544.0926,858,716.61
  专项储备1,427,312.81,370,431.971,236,897.271,096,278.59
  盈余公积138,000,248.18138,000,248.18138,000,248.18138,000,248.18
  未分配利润858,539,062.17830,583,330.59799,381,775.12786,273,191.36
  归属于母公司股东权益合计4,084,395,985.64,022,424,377.824,022,178,265.14,034,293,235.18
  少数股东权益-73,859,850.69-69,282,113.57-62,862,007.57-60,238,137.63
  股东权益合计4,010,536,134.913,953,142,264.253,959,316,257.533,974,055,097.55
  负债和股东权益合计5,042,124,951.524,979,827,984.074,959,489,610.84,861,024,246.2
公告日期2026-10-292026-08-272026-04-242026-04-23
审计意见(境内)标准无保留意见
TOP↑